Prophylactic Administration of Levosimendan in Patients With Impaired Left Ventricular Function Undergoing Coronary Surgery.

Trial Profile

Prophylactic Administration of Levosimendan in Patients With Impaired Left Ventricular Function Undergoing Coronary Surgery.

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 May 2014

At a glance

  • Drugs Levosimendan (Primary)
  • Indications Left ventricular dysfunction
  • Focus Therapeutic Use
  • Most Recent Events

    • 11 Mar 2014 According to ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
    • 27 Nov 2013 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
    • 27 Nov 2013 Planned end date changed from 1 Apr 2012 to 1 Dec 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top